BioSpecifics Announces Approval of XIAFLEX® in Japan for the Treatment of Dupuytren's Contracture

BioSyent Releases First Quarter 2014 Results-Sales Increase 59%, Net Income After Tax Up 49%

BioTime’s Subsidiary OncoCyte Corporation Announces Completion of Multi-Site Clinical Study of Lung Cancer Diagnostic by

Digital Currency News: Bit-X Financial Corp (OTCQB: BITXF) Provides Update on Launch of Bitcoin Exchange

"GO LIVE JUNE

Bonterra Identifies New "Barbeau Gold Zone" at the Gladiator

Bonterra Intersects High Grade Gold in New Zone at

Read more